The IKKβ aspect of the NF-κB pathway in particular is linked to the development of insulin resistance (190); inhibition of canonical IKKβ/NF-κB signaling actually improves skeletal muscle insulin sensitivity (191, 192) and prevents muscle degeneration and myofiber death (193–197). Here, NFKB1 is linked to Insulin resistance.